​

Funding Round

Series D - TMRW Life Sciences

Series D - TMRW Life Sciences

Investment Firm

Overview

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

Announced Date

Jul 12, 2024

Closed on Date

Jul 12, 2024

Funding Type

Series D

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

5AM Ventures

5AM Ventures

5AM Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorDF Capital
Participant InvestorCasdin Capital
Participant Investor5AM Ventures
Participant InvestorTransformation Capital
Participant InvestorGoogle Ventures

Round Details and Background

TMRW Life Sciences raised $28172940 on 2024-07-12 in Series D

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 20, 2021
Series C - TMRW Life Sciences
11-105.0M
Jul 21, 2021
Debt Financing - TMRW Life Sciences
-undefined
Dec 01, 2022
Angel Round - TMRW Life Sciences
1-undefined
Jul 12, 2024
Series D - TMRW Life Sciences
8-28.2M

Recent Activity

There is no recent news or activity for this profile.